These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 28539268

  • 1. MiR-221 mediates the epithelial-mesenchymal transition of hepatocellular carcinoma by targeting AdipoR1.
    Li T, Li M, Hu S, Cheng X, Gao Y, Jiang S, Yu Q, Zhang C, Sun P, Xian W, Song Z, Zhang Y, Zheng Q.
    Int J Biol Macromol; 2017 Oct; 103():1054-1061. PubMed ID: 28539268
    [Abstract] [Full Text] [Related]

  • 2. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
    Yu M, Xue H, Wang Y, Shen Q, Jiang Q, Zhang X, Li K, Jia M, Jia J, Xu J, Tian Y.
    Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY, Zhang K, Chen DQ, Chen J, Feng B, Song H, Chen Y, Zhu Z, Lu L, De W, Wang R, Chen LB.
    Oncotarget; 2015 Jul 30; 6(21):18613-30. PubMed ID: 26164082
    [Abstract] [Full Text] [Related]

  • 4. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
    Jin Y, Wang J, Han J, Luo D, Sun Z.
    Exp Cell Res; 2017 Nov 15; 360(2):210-217. PubMed ID: 28890291
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
    Xu Q, Liu X, Liu Z, Zhou Z, Wang Y, Tu J, Li L, Bao H, Yang L, Tu K.
    Mol Cancer; 2017 Jun 12; 16(1):103. PubMed ID: 28606154
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
    He Y, He X.
    Yonsei Med J; 2019 Mar 12; 60(3):267-276. PubMed ID: 30799589
    [Abstract] [Full Text] [Related]

  • 7. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
    Wang Y, Liu Z, Yao B, Li Q, Wang L, Wang C, Dou C, Xu M, Liu Q, Tu K.
    Mol Cancer; 2017 Jul 17; 16(1):123. PubMed ID: 28716020
    [Abstract] [Full Text] [Related]

  • 8. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R, Yu Z, Chen F, Xu H, Shen S, Chen W, Chen L, Su Q, Zhang L, Bi J, Zeng W, Li W, Huang X, Wang Q.
    Biomed Pharmacother; 2018 Jul 17; 103():1632-1642. PubMed ID: 29864952
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2.
    Ma DN, Chai ZT, Zhu XD, Zhang N, Zhan DH, Ye BG, Wang CH, Qin CD, Zhao YM, Zhu WP, Cao MQ, Gao DM, Sun HC, Tang ZY.
    J Hematol Oncol; 2016 Jan 06; 9():1. PubMed ID: 26733151
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. miR-650 Promotes the Metastasis and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Directly Inhibiting LATS2 Expression.
    Han LL, Yin XR, Zhang SQ.
    Cell Physiol Biochem; 2018 Jan 06; 51(3):1179-1192. PubMed ID: 30481780
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-616 promotes the migration, invasion and epithelial-mesenchymal transition of HCC by targeting PTEN.
    Zhang D, Zhou P, Wang W, Wang X, Li J, Sun X, Zhang L.
    Oncol Rep; 2016 Jan 06; 35(1):366-74. PubMed ID: 26499912
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MiR-429 regulates the metastasis and EMT of HCC cells through targeting RAB23.
    Xue H, Tian GY.
    Arch Biochem Biophys; 2018 Jan 01; 637():48-55. PubMed ID: 29191386
    [Abstract] [Full Text] [Related]

  • 16. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
    Qiu G, Lin Y, Zhang H, Wu D.
    Biochem Biophys Res Commun; 2015 Jul 31; 463(3):315-21. PubMed ID: 26022123
    [Abstract] [Full Text] [Related]

  • 17. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD, Wei JC, Qu K, Wang ZX, Wu QF, Tai MH, Liu HC, Zhang RY, Liu C.
    World J Gastroenterol; 2015 Jan 07; 21(1):196-213. PubMed ID: 25574092
    [Abstract] [Full Text] [Related]

  • 18. MiR-542-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting UBE3C.
    Tao J, Liu Z, Wang Y, Wang L, Yao B, Li Q, Wang C, Tu K, Liu Q.
    Biomed Pharmacother; 2017 Sep 07; 93():420-428. PubMed ID: 28666208
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma.
    Li D, Zhang Y, Zhang H, Zhan C, Li X, Ba T, Qiu Z, E F, Lv G, Zou C, Wang C, Si L, Zou C, Li Q, Gao X.
    J Exp Clin Cancer Res; 2018 Mar 05; 37(1):46. PubMed ID: 29506532
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.